COCP vs COIN · rev $105.0K vs P/E 64, rev $2.63B
Cocrystal Pharma Inc (COCP) versus Coinbase Global Inc (COIN) — a side-by-side from cached financials, not a winner call.
Cocrystal Pharma Inc (COCP) is a biotechnology company listed on US.
Coinbase Global Inc (COIN) is a financial data & stock exchanges company listed on US. It is led by Brian Armstrong.
Latest reported COCP revenue for 2026-06-30 was $105.0K. Net income was -$3.2M. Revenue was down 53.3% from 2026-03-31 to 2026-06-30. COCP currently screens at market cap $13.3M.
Latest reported COIN revenue for 2026-06-30 was $2.63B. Net income was -$753.6M. Revenue was up 86.3% from 2026-03-31 to 2026-06-30. COIN currently screens at market cap $45.84B and trailing P/E 64.2.
COCP currently screens at market cap $13.3M. COIN currently screens at market cap $45.84B and trailing P/E 64.2.
Not investment advice. Open the COCP and COIN stock pages for the full models.
Not investment advice.